The expression of components of the adrenomedullin (AM) system (AM and its receptors) has been detected in mammalian adrenal zona glomerulosa (ZG) cells, and evidence has been provided that AM is able to inhibit agonist-stimulated aldosterone secretion from and to enhance the proliferative activity of ZG cells. 
Introduction
Adrenomedullin (AM) is a hypotensive peptide originally isolated from human pheochromocytomas (1) . AM is produced by the proteolytic cleavage of proadrenomedullin (pAM), and acts via at least two subtypes of receptors, the adrenal zona glomerulosa (ZG) possesses AM-binding sites, and is one of the main targets of this peptide (for review, see . AM, acting via calcitonin gene-related peptide (CGRP)8-37-and AM22-52-sensitive receptors, has been found 1) to inhibit angiotensin-II (Ang-II)-and K -stimulated aldosterone secretion, and 2) to enhance the growth of ZG cells both in vivo and in vitro. Evidence has been provided that the pAM gene is expressed in rat (8) and human ZG cells (9) , as well as in several benign and malignant adrenocortical tumors (10, 11) and the adrenocortical carcinoma cell lines SW13 and NCI-H295 (12) (13) (14) . Moreover, low but sizeable concentrations of immunoreactive (ir)-AM have been detected in dispersed human and rat ZG and aldosteronoma cells (8, 9, 11) , as well as in the culture medium of the SW13 cell line (13, 14) . Collectively, these observations, along with the demonstration that human and rat ZG and NCI-H295 cells express both L1-R and CRLR/RAMP2 receptors (8, 9, 15, 16) , make it likely that the effects of AM on adrenocortical cells occur via an autocrine/paracrine mechanism.
Unfortunately, in all the short-term experiments performed to date, the antagonists of AM receptors CGRP8-37 and AM22-52 were found to be per se unable to affect either the agonist-stimulated aldosterone secretion or basal proliferative activity of ZG cells (reviewed in Ref. 7) , thereby casting doubt on the physiological relevance of the role of the endogenous AM system in the functional regulation of ZG. However, Miller et al. (12) reported that AM immunoneutralization significantly lowered the proliferation rate of the cultured NCI-H295 cell line, and we have recently observed that a 48-h, but not a 24-h, exposure of cultured rat ZG cells to AM22-52 evoked a weak antiproliferative and proapoptotic effect, suggesting that a prolonged suppression of the endogenous AM system is probably needed for its effect on cell growth to become appreciable (8) .
Based on this last assumption, we decided to use aldosterone-secreting long-term cultures of rat ZG cells, and to ascertain whether the suppression of endogenous AM production by the antisense oligodeoxynucleotide (ODN) technique is able to modify their secretory response to agonists and/or their basal growth rate.
Methods

Animals and Reagents
Sprague-Dawley male rats (250-270 g body weight) were purchased from Charles-River (Como, Italy), and the experiment protocol was approved by the local Ethics Committee for Animal Studies. All chemicals and reagents were provided by Sigma Chemical Company (St. Louis, USA), with the following exceptions: AM antisense and scrambled sense ODNs, and pAM primers were obtained from Sigma Genosis (Pampisford, UK), Effectene Transfection Reagent (ETR) and the QIA purification kit from Qiagen (Hilden, Germany), Dulbecco's modified Eagle's minimum essential medium (DMEM) from Gibco (Paisley, UK), and the DAB kit from DAKO (Carpinteria, USA).
In Vitro Culture
Rats were decapitated, and their adrenal glands were promptly removed under sterile conditions. ZG was separated from inner zones by gently stripping the gland capsule, and dispersed ZG and ZF/R cells were obtained by sequential collagenase digestion and mechanical disaggregation (17) . Dispersed cells were suspended in DMEM containing 100 U/ml penicillin and 100 µg/ml streptomycin, and 0.6 µg/ml ODNs in ETR vehicle, and plated in 35-mm tissue culture dishes. In the gene expression and secretion experiments, ZG cells were seeded at a density of 5 10 5 cells/dish to obtain confluency after 24 h of culture, while in the growth experiments cells were seeded at a density of 10 4 cells/dish. ODNs were chosen according to Samson et al. (18) : AM antisense (A)-ODN, 5 -cagCTTCATTTCgtA-3 ; scrambled sense (S)-ODN, 5 -catCTGCTTTAtacG-3 . Previous pilot experiments carried out on dispersed adrenocortical cells showed that 600/700 ng/ml is the maximum ODN concentration that can be used without toxicity. Cultures were incubated for 60 min at 37 ºC in a humidified atmosphere of 95% air -5% CO2, then medium was replaced with DMEM containing 10% fetal calf serum (FCS), and 10 12 mol/l adrenocorticotropic hormone (ACTH) and 2 10 12 mol/l Ang-II. The treatment with ODNs was repeated after 24 h, and after 60 min of incubation the medium was replaced with fresh medium (time 0) and cells were cultured up to 8 days. In some experiments cultured cells were not treated with ODNs, and in others FCS was added to DMEM at a concentration of 2% to raise the apoptotic rate of cultured cells.
At time 0 and 2, 4, 6 and 8 days after ODN treatment, confluent cultures were incubated for 120 min in the presence of ACTH (10 9 mol/l), Ang-II (10 9 mol/l) or K (10 2 mol/l) or without any agonist (baseline value). The medium was then collected and replaced with fresh medium. Non confluent cultures were not treated with the agonists, and were used at time 0 and 2, 4, 6 and 8 days after ODN treatment. During the last 6 h of each incubation time some cultures were supplemented with medium containing 5 -bromo-2 deoxyuridine (BrdU) at a final concentration of 20 mg/ml (19) .
Reverse Transcription (RT)-Polymerase Chain Reaction (PCR)
Total RNA was extracted from detached and harvested ODN-treated and untreated cultured cells, as well as from freshly dispersed cell samples, and reverse-transcribed to derive cDNA (20) . PCR was carried out in a thermal cycler (Perkin-Elmer 480 DNA TC; Perkin-Elmer Life Sciences, Milan, Italy) using the following amplification conditions: an initial step at 95 ºC for 10 min, followed by 40 cycles of a denaturation step at 95 ºC for 45 s, an annealing step at 57 ºC glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or 60 ºC pAM for 45 s, and an extension step at 72 ºC for 45 s. An additional extension step at 72 ºC for 8 min was then carried out. The primer sequences and sizes of PCR products were as follows: 1) rat AM: sense (418-5 ), 5 -ACTCAGAGCA CAGCCCACAT-3 and antisense (1294-3 ), 5 -ATCAGGC GCTCTCCACCTTA-3 (expected size of amplicon, 877 bp); and 2) GAPDH: sense (181-5 ), 5 -CCCTTCATTGACCT CAACTA-3 and antisense (765-3 ), 5 -GCCAGTGAGCTT CCCGTTCA-3 (expected size of amplicon, 585 bp). To rule out the possibility of amplifying genomic DNA, one PCR was carried out without prior RT of the RNA (data not shown). Detection of the PCR amplification products was first performed by size fractionation using 2% agarose-gel electrophoresis. Then, after purification using the QIA quick PCR purification kit, PCR products were identified by sequencing on an Alf sequencer (Pharmacia Biothech, Freiburg, Germany).
AM and Aldosterone Radioimmunoassay (RIA)
ODN-treated and untreated cultures (cells and incubation medium) were processed for RIA of rat AM (21) . AM was separated and purified by chromatography using a Sep-Pack C18 cartridge (Waters, Milford, USA). Rat ir-AM concentration in the eluates was determined using a commercial RIA kit (Phoenix Pharmaceuticals, Belmont, USA) (sensitivity: 5 pmol/l; cross-reactivity: rat AM 100%, human AM and other peptides 0; intra-and interassay coefficient of variations: 7.5% and 9.2%, respectively). Aldosterone was extracted from incubation media, and purified by high-pressure liquid chromatography (22) . Its concentration was measured using an ALDO-CTK2 RIA kit (IRE-Sorin, Vercelli, Italy) (sensitivity: 15 pmol/l; cross-reactivity: aldosterone 100%, 17-iso-aldosterone, and other steroids 0.1%; intra-and interassay coefficients of variations: 6.9% and 8.4%, respectively).
Cell Proliferation and Apoptosis
ODN-untreated and ODN-treated cultures were fixed in a 3:1 methanol/acetic acid solution, and stained with hematoxylin and eosin. The growth rate was measured by a computerized system settled in an inverted Axiovert 100 microscope (KarlZeiss, Jena, Germany). The growth data, expressed as the mean number of cells/mm 2 , were utilized to estimate the cell duplication time according to the exponential growth sloop processed by GrafPad Prism software. Other cultures were fixed in 4% paraformaldehyde for 30 min. BrdU-positive cells were detected using a Cell Proliferation Kit from Amersham Pharmacia (Aylesbury, UK), and apoptotic cells using a Sigma TACS Klenow In situ Apoptosis Detection Kit. Peroxidase-positive cells were evidenced using a DAB kit, and their percentage was evaluated by counting 1,000 cells per culture dish.
Statistics
Data were expressed as the mean SEM, with six or eight culture dishes being employed for each experimental point. Statistical comparisons were made using analysis of variance, followed by Duncan's multiple range test.
Results
AM Expression
RT-PCR allowed the detection of pAM mRNA in both freshly dispersed ZG cells and untreated or S-ODN-treated (here-
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Fig. 1. The effect of A-ODN on pAM mRNA expression in cultured ZG cells, in relation to the time elapsed from incubation with ODN. Ethidium bromide-stained 2% agarose gel showing cDNA amplified with rat pAM (a) and GAPDH (b) specific primers from RNA of two exemplary freshly dispersed ZG cells (DC) and ODN-untreated ZG cells (UT) at day 6 of culture (panel A), and of an exemplary S-ODN-treated (panel B) and an A-ODN-treated ZG-cell culture (panel C) at days 0, 2, 4, 6 and 8. No amplification was observed when water instead of RNA was used. The size marker was a 200 ng Marker VIII (Boehringer, Mannheim, Germany).
inafter, control) cultured ZG cells (Fig. 1) , and RIA demonstrated low ir-AM concentrations (Fig. 2) . ZF/R cell cultures were negative (data not shown). The A-ODN treatment suppressed AM mRNA and protein expression in 4-and 6-day ZG cell cultures. After 8 days, a low expression of pAM mRNA and protein was again detected (Figs. 1, 2 ).
Hormone Secretion
Control ZG cell (S-ODN-treated) cultures maintained unchanged basal and agonist-stimulated rates of aldosterone secretion until day 8 (Figs. 3-5) , and did not display significant differences from ODN-untreated cultures (data not shown). As compared with control cultures, A-ODN-treated cultures showed significantly enhanced aldosterone response to both Ang-II and K at days 4 and 6 (but not at days 2 and 8) (Figs. 3, 4) . In contrast, aldosterone response to ACTH was not affected by A-ODN treatment (Fig. 5) . ZF/R cell cultures displayed secretory (corticosterone) responses to ACTH, but not Ang-II and K , and the response was not modified by ODN treatment (data not shown).
Growth Rate
The growth assay showed that ODN-untreated and control ZG cells underwent a slow exponential growth in culture, the duplication times being about 138 h and 125 h, respectively. A-ODN treatment increased this figure to about 180 h ( 
Fig. 3. The effect of A-ODN on Ang-II (10 9 mol/l)-induced secretion of aldosterone in cultured ZG cells, in relation to the time elapsed from the incubation with the ODN. Basal and Ang-II-stimulated secretions from S-ODN-treated and A-ODN-treated cultures are shown in panels A and B, respectively. Aldosterone response to Ang-II (expressed as a % change from the respective baseline value) of S-ODN-treated (ST) and A-ODN-treated cultures (AT) are compared in panel C. Bars are the means SEM (n 6
Fig. 2. The effect of A-ODN on the AM protein expression in cultured ZG cells, in relation to the time elapsed from the incubation with the ODN. The ir-AM concentrations in ODN-untreated (UT), S-ODN-treated (ST) and A-ODNtreated (AT) cells are shown. Bars are the means SEM (n 8).
p 0.01 from the respective UT and ST groups; other differences among the UT, ST and AT groups were not significant (p 0.05). (Fig. 7) . The apoptotic index showed a small rise in control cells at day 2, and remained unchanged thereafter. A-ODN-treated cultures displayed a marked rise in apoptotic index at days 4, 6 and 8 (Fig. 7) . Again, ODN treatment did not modify either the proliferation or apoptotic index of cultured ZF/R cells (data not shown).
8-day cultures
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Fig. 5. Lack of effect of A-ODN on ACTH (10 9 mol/l)-induced secretion of aldosterone in cultured ZG cells. Basal and ACTH-stimulated secretion from S-ODN-treated and A-ODN-treated cultures are shown in panels A and B, respectively. Aldosterone responses to ACTH (expressed as a % change from the respective baseline value) of S-ODNtreated (ST) and A-ODN-treated cultures (AT) are compared in panel C. Bars are the means SEM (n 6).
p 0.01 from the respective baseline value. 
Discussion
Our present findings confirm that rat ZG cells express the pAM gene (8) , and also demonstrate that our culture conditions apparently do not influence the phenotype of ZG cells, as evidenced by their ability to secrete aldosterone. They also validate the use of antisense ODNs to block the endogenous AM system, inasmuch as treatment with A-ODN, but not S-ODN, suppresses AM-gene transcription and translation in cultured ZG cells. The suppression of AM synthesis is long-lasting, persisting for at least 6 days after A-ODN treatment, and requires at least 2 days to become apparent: a period of time conceivably needed to exhaust the store of previously synthesized mRNA and peptide.
With few exceptions (15, 23) , all previous investigations agree that AM selectively inhibits Ang-II-and K -stimulated aldosterone secretion from dispersed rat (24) (25) (26) and human ZG cells (27) (28) (29) (30) , without affecting either basal or ACTH-stimulated secretion or the secretory activity of ZF/R cells. Accordingly, in vivo studies have shown that AM administration does not affect basal aldosterone plasma concentration in control rats, but significantly decreases it in animals given a sodium-deficient diet (31, 32) , and in two-kidney, one clip hypertensive rats (33) . Our present observations are in keeping with these findings, and provide strong evidence that the long-term suppression of endogenous AM synthesis induces a significant enhancement in the aldosterone response of ZG cells to Ang-II and K , but not ACTH. The effect becomes appreciable in 4-day cultures when the previously transcribed pAM mRNA stores are completely depleted, and disappears in 8-day cultures when AM synthesis is released from the A-ODN-induced blockade.
Mounting evidence indicates that AM acts as a growth promoter on rat and human ZG (8, 9, 34, 35) and aldosteronoma cells (11) , not only by stimulating proliferation, but also by decreasing apoptotic deletion in FCS-deprived cultured cells (8, 9) . Our study confirms this contention and clearly shows that the endogenous AM system is involved in the normal growth maintenance of cultured rat ZG cells by exerting both a proliferogenic and an antiapoptotic action. In fact, the A-ODN-induced suppression of AM synthesis elongates the duplication time of cultured ZG cells by about 40%, and within 4 days significantly lowers their proliferation index and raises their apoptotic index.
The antiproliferogenic and proapoptotic effects of the blockade of the endogenous AM system are still significant 8 days after A-ODN administration, and this is at variance with the effect on aldosterone response to Ang-II and K . At present, it is very difficult to explain this discrepancy. However, we recall that there is proof that the aldosterone anti- secretagogue action of AM mainly involves the acute impairment of agonist-stimulated voltage-gated Ca 2 channels (26), while the growth-promoting effect of AM is mediated by mitogen-activated protein kinase (MAPK) activation (34, 35) . It is conceivable that an active endogenous AM system is needed for the functional maintenance of ZG MAPKs, and that the recovery of the MAPK cascade, which can start after the release of endogenous AM synthesis from the A-ODNinduced blockade, requires at least 48 h for completion.
Be that as it may, our study demonstrates for the first time that the endogenous AM system plays a role in the autocrine/paracrine control of rat ZG functions, at least under in vitro culture conditions, by exerting a buffering action on agonist-stimulated aldosterone secretion and by maintaining a normal growth rate via both a proliferogenic and an antiapoptotic action.
